Co-Diagnostics forms new AI business unit

Co-Diagnostics (CODX) announced the formation of a newly organized, artificial intelligence business unit, led by Chief Technology & AI Officer Christopher Thurston, to integrate the company’s existing and planned AI applications into the Co-Dx Primer Ai platform. Co-Dx anticipates that allocating resources to the newly formed AI business unit will enable the company to develop proprietary AI-powered diagnostics more efficiently and reduce time-to-market for new tests. The company also believes that future AI tools will be able to leverage the analytics yielded from widespread deployment and commercialization of the Co-Dx PCR Pro to improve situational awareness during a health crisis, and potentially predict outbreaks and pandemics before they occur.